Navigation Links
Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
Date:1/14/2009

ATLANTA, Jan. 14 /PRNewswire/ -- A patient who allegedly was seriously injured by Medtronic, Inc.'s Infuse(R) Bone Graft implant in an off-label surgical procedure promoted by Medtronic has sued the company, according to James A. Dunlap Jr. & Associates LLC and Page Perry, LLC.

The firms, along with co-counsel Lieff, Cabraser, Heimann & Bernstein, LLP, filed suit in New York federal court on behalf of Paul and Susan Antonelli, of Amsterdam, N.Y. The suit alleges that Mr. Antonelli was injured during a failed January 2006 procedure at a New York hospital to fuse vertebrae in his spine.

"The Antonelli family has suffered tremendously, and Mr. Antonelli remains in agonizing pain," said James A. Dunlap, one of the attorneys representing the Antonelli family. "Because of Medtronic's wrongful conduct, many other patients like Paul Antonelli may have improperly received Medtronic's Infuse(R) Bone Graft product for an off-label use."

The Complaint alleges, among other things, that Medtronic (NYSE: MDT) improperly promoted its Infuse(R) Bone Graft product for a cervical lumbar surgery procedure, when the product was not approved by the U.S. Food and Drug Administration for that use. Infuse(R) Bone Graft product may cause severe swelling in the neck and throat that restricts breathing and can lead to suffocation of the patient if used off-label for unapproved uses, particularly spinal surgery performed from the back.

The FDA has received more than 200 reports of significant side effects resulting from off-label use of the medical device, particularly in the cervical spine, a number of which have led to serious and potentially life-threatening complications.

The lawsuit alleges that Mr. Antonelli's post-operative period was marked by increasingly severe pain, selling of the neck, mental status changes, difficulty swallowing, and difficulty breathing during which he nearly suffocated. He then required an emergency bedside tracheotomy after a few of his front teeth were knocked out in an effort to intubate him.

Medtronic's Infuse(R) Bone Graft product has been the subject of a recent whistleblower lawsuit brought by former Medtronic employees who alleged that doctors received more than $8 million in 2006 in "sham" consulting fees for using and promoting the Infuse(R) Bone Graft product. Medtronic's marketing and promotion of the device for off-label uses is being investigated by the U.S. Department of Justice. In addition, the U.S. Senate is conducting hearings into the matter. Medtronic previously settled for $40 million with the Justice Department on another whistleblower action alleging that, between 1998 and 2003, Medtronic's spinal products division paid kickbacks to doctors in a number of forms, including sham consulting agreements, sham royalty agreements and lavish trips to desirable locations.

The case is "Paul and Susan Antonelli v. Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc.," in the U.S. District Court, Southern District of New York (Case No. 09 CV 00183).

For additional information or to request a copy of the Complaint, contact James Dunlap, James A. Dunlap Jr. & Associates LLC at 404.354.2363, www.jamesdunlaplaw.com, or Page Perry, LLC, at 770.673.0047, www.pageperry.com.


'/>"/>
SOURCE James A. Dunlap Jr. & Associates LLC; Page Perry, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
2. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
3. Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
4. Supreme Court Hears Case on Federal Pre-emption of Safety Standards for Medical Technologies (Riegel v. Medtronic, Inc.)
5. Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc.
6. Court Rejects Two Medtronic Patents
7. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
8. Medtronic Celebration of Courage Set for September 13th
9. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
10. Medtronic Mediterranean Launches Worlds First Arabic-Language Integrated Insulin Therapy for Improved Diabetes Management
11. Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... News Advisory/Interview Opportunity , After six years of advocacy, ... in Europe for public health and the environment and is calling on the United ... and the overwhelming support of European citizens, the European Union (EU) will, beginning next ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden Clinic, the largest multi-specialty ... payment system, to expand its focus on patient care by providing an advanced ... , “At Ogden Clinic, we are working to become a different type of ...
(Date:3/23/2017)... ... March 23, 2017 , ... Vortex ... of “Profiling protein expression in circulating tumor cells using microfluidic western blotting” in ... of the Vortex technology to capture CTCs and a microfluidic single-CTC ...
(Date:3/22/2017)... ... 22, 2017 , ... Sam & Associates Insurance Agency, a ... related services to residents of the region, is embarking on a charity effort ... wild lands. , Endangered Species International is committed to ending the anthropogenic trends ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... consuming and frustrating and this tool bypasses that. Healthcare facilities across the ... an opportunity to offer their clients and hospitals, across the country, an efficient ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... NEW YORK , March 22, 2017 ... ... cannabis market was worth an estimated $6.6 billion in 2016, and ... of 16% or reaching more than $24 billion by 2025. The ... 2025, or growing from $4.7 billion in 2016, to an estimated ...
(Date:3/22/2017)... 22, 2017 FinancialBuzz.com News Commentary ... rapidly due to the significant development and innovation in ... Market Research, the global electrophysiology market was worth $3.42 ... billion by 2022, with a GAGR of 13.4%. Electrophysiology ... diagnose abnormal heartbeats or arrhythmia. The report indicates that ...
(Date:3/22/2017)... MAPLE GROVE, Minn. , March 22, 2017   ... of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and ... (clomipramine hydrochloride) Capsules USP. The clomipramine ... for the 12 months ending December 2016, according to IMS ... ...
Breaking Medicine Technology: